Generic Prescription Drug Shortage Bills
AAM’s core mission is to improve patients’ lives by advancing timely access to affordable, FDA-approved generic and biosimilar medicines. AAM is the nation’s leading trade association for manufacturers and distributors of generic and biosimilar prescription medicines. Our members provide more than 36,000 jobs at nearly 150 facilities, and manufacture more than 61 billion doses of […]
AAM Statement on 2019 FDA Drug Shortages Task Force Report
WASHINGTON DC (October 29, 2019) – AAM applauds FDA for recognizing the multi-faceted challenges that can lead to drug shortages. In particular, deteriorating market conditions have led to sustainability issues in the manufacture of certain medicines. AAM and its members commit to working with FDA and policymakers to advocate for policies to ensure a healthy, […]
Preliminary Recommendations for Addressing Drug Shortages
AAM appreciates FDA’s efforts to address drug shortages, and we look forward to working with the Agency to further refine potential options as the agency moves forward with the important work on drug shortages. Ensuring patient access to needed drug products involves several stakeholders throughout the key stages of a product’s process – starting with […]
